Literature DB >> 7530348

The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin.

T M Dawson1, J P Steiner, W E Lyons, M Fotuhi, M Blue, S H Snyder.   

Abstract

The immunosuppressant drugs cyclosporin A and FK506 bind to small, predominantly soluble proteins cyclophilin and FK506 binding protein, respectively, to mediate their pharmacological actions. The immunosuppressant actions of these drugs occur through binding of cyclophilin-cyclosporin A and FK506 binding protein-FK506 complexes to the calcium-calmodulin-dependent protein phosphatase, calcineurin, inhibiting phosphatase activity. Utilizing immunohistochemistry, in situ hybridization and autoradiography, we have localized protein and messenger RNA for FK506 binding protein, cyclophilin and calcineurin. All three proteins and/or messages exhibit a heterogenous distribution through the brain and spinal cord, with the majority of the localizations being neuronal. We observe a striking co-localization of FK506 binding protein and calcineurin in most brain regions and a close similarity between calcineurin and cyclophilin. FK506 binding protein and cyclophilin localizations largely correspond to those of calcineurin, although cyclophilin is enriched in some brain areas that lack calcineurin. The dramatic similarities in localization of FK506 binding proteins and cyclophilins with calcineurin suggest related functions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530348     DOI: 10.1016/0306-4522(94)90389-1

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  26 in total

1.  Spontaneous intracranial hypotension-hypovolemia associated with tacrolimus.

Authors:  Andrew H Ahn; Brian D Berman; William P Dillon
Journal:  Headache       Date:  2010-05-31       Impact factor: 5.887

2.  Design and structure-based study of new potential FKBP12 inhibitors.

Authors:  Fei Sun; Pengyun Li; Yi Ding; Liwei Wang; Mark Bartlam; Cuilin Shu; Beifen Shen; Hualiang Jiang; Song Li; Zihe Rao
Journal:  Biophys J       Date:  2003-11       Impact factor: 4.033

3.  Ca2+/calcineurin-inhibited adenylyl cyclase, highly abundant in forebrain regions, is important for learning and memory.

Authors:  F A Antoni; M Palkovits; J Simpson; S M Smith; A L Leitch; R Rosie; G Fink; J M Paterson
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 4.  Cellular catabolism in apoptosis: DNA degradation and endonuclease activation.

Authors:  J W Montague; J A Cidlowski
Journal:  Experientia       Date:  1996-10-31

5.  Postsynaptic calcineurin activity downregulates synaptic transmission by weakening intracellular Ca2+ signaling mechanisms in hippocampal CA1 neurons.

Authors:  J H Wang; P T Kelly
Journal:  J Neurosci       Date:  1997-06-15       Impact factor: 6.167

6.  Identification of parvalbumin alpha in bovine hypothalamus: a partial primary structure.

Authors:  T A Egorov; A A Galoyan
Journal:  Neurochem Res       Date:  1997-07       Impact factor: 3.996

7.  Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism.

Authors:  S P Butcher; D C Henshall; Y Teramura; K Iwasaki; J Sharkey
Journal:  J Neurosci       Date:  1997-09-15       Impact factor: 6.167

8.  FKBP12: A partner of Snx10 required for vesicular trafficking in osteoclasts.

Authors:  Ricardo A Battaglino; Prakash Jha; Farhath Sultana; Weimin Liu; Leslie R Morse
Journal:  J Cell Biochem       Date:  2019-03-19       Impact factor: 4.429

Review 9.  Computational drug discovery.

Authors:  Si-Sheng Ou-Yang; Jun-Yan Lu; Xiang-Qian Kong; Zhong-Jie Liang; Cheng Luo; Hualiang Jiang
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

10.  Familial hemiplegic migraine Ca(v)2.1 channel mutation R192Q enhances ATP-gated P2X3 receptor activity of mouse sensory ganglion neurons mediating trigeminal pain.

Authors:  Asha Nair; Manuela Simonetti; Nicol Birsa; Michel D Ferrari; Arn M J M van den Maagdenberg; Rashid Giniatullin; Andrea Nistri; Elsa Fabbretti
Journal:  Mol Pain       Date:  2010-08-24       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.